Kenan Turnacioglu
Chair of B.O.D at Paige
Kenan Turnacioglu
Chair of B.O.D at Paige
New York City Metropolitan Area
Overview
Work Experience
Board Member
2022 - Current
Board Member
2020
Member Board Of Directors
2020 - 2022
Board Member
2020 - 2022
Chair Of The Board Of Directors
2017
· Company spun out of Memorial Sloan Kettering with goal of applying machine · Learning/artificial intelligence to supplement the pathologist in diagnosis.
General Partner & Member of the Investment Committee
2020 - 2021
Catalio Capital Management invests in breakthrough biomedical technologies companies around the globe.
Founding Partner
2011 - 2018
· Founding Partner of Firm that was launched with $4.25bn in assets and grew to $10bn · Managed on average $2bn in capital in Healthcare, Consumer, and TMT · Oversaw the development of the firms Technology and Media group · Oversaw the development of a data science team to analyze large data set · Returns of mid-teens from 2011 to 2017 · Departed firm at end of 2017 to retire from money management business
Executive Board Member
2013 - 2016
· Company focused on cancer stem cells as targets for antibody therapeutics · Valuation at the time of sale to Abbvie $6.2BN with potential of CVR $4.0BN
Portfolio Manager
2001 - 2010
· Portfolio Manager covering Global Healthcare Industry · Started out as an analyst covering biotech · Portfolio Manager covering Global Healthcare Industry mid-teens returns · Company dissolved in 2010 with the retirement of Founder, Stanley Druckenmiller
Executive Board Member
2004 - 2007
· Company focused on developing antibody therapeutics for cancer targets · Valuation at the time of sale to Astellas was $527mm
Research associate
1999 - 2001
· Research associate covering the biotechnology sector · Initiated on several genomic and antibody companies